Transcranial electrical stimulation (tES) enjoys a burgeoning reputation in basic and clinical research, and home-use. Even though Rush and Driscoll highlighted more than 40 years ago that "the amount of current entering the brain is of great consequence" [9], to this day tES studies generally do not control how much current is actually delivered to the brain. Instead, tES applications control the output of a stimulator, and so for most applications we do not control that comparable doses of current are delivered to the brain of different individuals. Yet we do know that the idiosyncratic properties of the head strongly influence how much of a fixed output current (e.g. 1mA) will reach the brain [1], and so we are in the extraordinary position of knowing that the effective dose of tES is highly variable across individuals (Figure 1), yet doing very little about it.The recent debate scrutinizing the efficacy, reliability and utility of tES [4,5,10] thus misses a vital point that likely contributes to variable outcomes. For a given stimulator output, current in a cortical target region may vary by up to 100% across individuals [7]. For the field to mature, and the clinical promise of tES to be rigorously tested, not knowing how much current we deliver or where this current might travel, will remain an unacceptable barrier. This is especially the case in clinical applications such chronic stroke where results have been rather mixed [3], and where the distortions of current flow that the lesions impose may amplify variability in effectively delivered current.